Design Therapeutics is a biotechnology company that is focused on developing treatments for serious degenerative disorders. The company's lead product candidate is a small molecule drug that is designed to treat Friedreich's ataxia, a rare genetic disease that affects the nervous system. Design Therapeutics was founded in 2017 and is headquartered in San Diego, California.